Search query

Investors & News

Search query

Company Overview
Leadership Team
Careers
Contact Us

We are dedicated to transforming cardiovascular muscle diseases.

Learn More

Pipeline
EDG-7500
EDG-15400
Clinical Trials
Posters & Presentations
Cardiovascular Diseases

All of us at Edgewise are committed to developing new medicines for people facing serious cardiovascular diseases with unmet medical needs.

Explore our pipeline

Patients & Families Overview

Corporate Profile
News
Events & Presentations
Analyst Coverage
Stock Info
Financials
- Quarterly Results
- SEC Filings

Governance
- Governance Documents
- Committee Composition
Resources

Investors & News

Information Request Form

Name *

Name is required

Email Address *

Email Address is required

Subject

Comment

Quick Links

SEC Filings
Leadership Team
Posters & Presentations

IR Contact

ir@edgewisetx.com

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

Edgewise Therapeutics, Inc, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Edgewise Therapeutics, Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address *

Investor Alert Options

Investor Alert Options *

News

Events & Presentations

Quarterly Reports

SEC Filings

End of Day Stock Quote

Unsubscribe